BIRC5 and cancer: High levels of survivin expression in cancer cells are associated with poor patient prognosis and survival, as well as with resistance to therapy and an increased rate of cancer recurrence (Monzo et al, 1999; Altieri, 2001; Rodel et al, 2005).